10 studies found for:    FMR1
Show Display Options
RSS Create an RSS feed from your search for:
FMR1
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Terminated The Natural History of Reproductive and Overall Health in Girls and Women With a Pre-Mutation in the FMR1 Gene; Creation of a Patient Registry
Conditions: Fragile X Syndrome;   FMR1 Premutation;   Primary Ovairan Insufficiency;   Premature Ovarian Failure;   Premature Menopause
Intervention:
2 Terminated Analysis of Oculo-motor Deficiencies Associated With FMR1 Gene Expression (Genetic Abnormality Predisposing to a Neurodegenerative Disease)
Condition: Pre-mutation on FMR1 Gene
Interventions: Other: examination of ocular movements;   Other: MATTIS test;   Other: UPDRS test;   Other: CRST test
3 Completed Examining Physiology and Brain Function in People With the Fragile X Premutation
Condition: Fragile X Premutation
Intervention:
4 Unknown  Safety and Efficacy Study of Antioxidants for the Treatment of the Fragile X Syndrome
Condition: Fragile X Syndrome
Interventions: Dietary Supplement: Ascorbic Acid (Vitamin C) and Alpha-tocopherol (Vitamin E);   Other: Placebo
5 Unknown  Premature Ovarian Failure (Genetic and Physiopathologic Analysis)
Condition: Premature Ovarian Failure
Intervention:
6 Completed Examining Social, Emotional, and Cognitive Functioning in People With Fragile X and Down Syndromes
Conditions: Anxiety Disorders;   Child Developmental Disorders, Pervasive
Intervention:
7 Completed Study to Evaluate the Efficacy and Safety of Subsequent Treatment With the Zevalin (Ibritumomab Tiuxetan) Study in Patients With Follicular Grade I-II Lymphoma After 4 Cycles of Fludarabine-Mitoxantrone-Rituximab (FMR) Therapy
Condition: Follicular Lymphoma
Interventions: Drug: FM+R;   Drug: Zevalin (Ibritumomab Tiuxetan)
8 Completed Chemotherapy Followed by Zevalin for Relapsed Mantle Cell Lymphoma
Condition: Mantle Cell Lymphoma
Interventions: Drug: Fludarabine;   Drug: Mitoxantrone;   Drug: Rituximab;   Drug: Zevalin
9 Unknown  Effect of a Novel Nutraceutical on Weight Loss and Weight Maintenance in Obese Subjects
Condition: Obesity
Interventions: Dietary Supplement: THIAA;   Dietary Supplement: Placebo
10 Unknown  VIVID - Valvular and Ventricular Improvement Via iCoapsys Delivery - Feasibility Study
Conditions: Mitral Valve Regurgitation;   Left Ventricular Dysfunction;   Heart Failure;   Mitral Insufficiency;   Mitral Incompetence;   Ischemic Heart Disease
Intervention: Device: Percutaneous mitral valve repair

Indicates status has not been verified in more than two years